Congress trades in Jazz Pharmaceuticals (JAZZ)
Healthcare · Biotechnology
2 members of Congress have disclosed 2 trades in Jazz Pharmaceuticals (JAZZ) since 2023: 0 buys and 2 sales. The most recent was disclosed on Aug 13, 2023.
- Trades disclosed
- 2
- Members trading
- 2
- Buys / sells
- 0 / 2
- Reported value
- $16K–$65K
Who traded JAZZ
MemberBuysSalesLast disclosed
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01Aug 13, 2023
- Rep. Ro Khanna (D-CA-17)0 buys · 1 sale01Jun 12, 2023
All trades
DisclosedTradeAmount
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Sold (full) Jazz Pharmaceuticals JAZZ
$15K–$50K · Traded Jul 12, 2023 · disclosed Aug 13, 2023
- Jun 12, 2023$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Jazz Pharmaceuticals JAZZ
$1K–$15K · Traded May 19, 2023 · disclosed Jun 12, 2023 · Spouse
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.